The Society for Immunotherapy of Cancer (SITC) hosted "Concurrent Session 310: Combination Phase 1-2 Clinical Trials" during the SITC 2019 Annual Meeting on November 9, 2019. Available here are the presentation slides and video from the session.
34th Annual Meeting Organizers
Session Co-Chairs
To view the entire program schedule (including presenter permission to post) please click here.
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Pavlos Msaouel, MD, PhD – The University of Texas MD Anderson Cancer Center; Date: November 9, 201900:16:06
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Joseph Tintelnot, MD – University Medical Center Hamburg-Eppendorf; Date: November 9, 201900:13:47
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Ulka N. Vaishampayan, MD – Wayne State University and Barbara Ann Karmanos Cancer Institute; Date: November 9, 201900:13:43
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Alexander N. Shoushtari, MD – Memorial Sloan Kettering Cancer Center; Date: November 9, 201900:16:57
Meeting: SITC 34th Annual Meeting; Concurrent Session 310: Combination Phase 1-2 Clinical Trials; Presenter: Adi Diab, MD – The University of Texas MD Anderson Cancer Center; Date: November 9, 201900:14:37
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us